ANTIBODIES

CancerTools.org: The home for cancer research tools

Back

Anti-CHIKV [11E7]

Cat. #153201

Tool name: Anti-CHIKV [11E7]
Alternate names: Chikungunya virus
Clone: [11E7]
Tool type: Antibodies
Class: Monoclonal
Conjugate: Unconjugated
Reactivity: Virus
Host: Mouse
Application: IF ; WB
Description: Chikungunya virus (CHIKV) is known to be transmitted to humans by mosquito vectors, primarily Aedes aegypti and A. albopictus. Symptoms of chikungunya infection generally initiated 4ÄËĂÂĂÂ7 days after the bite of the mosquito vector and usually include high fever, asthenia, chills, headache, diarrhoea, vomiting and rash. CHIKV gained its infamity from the severe outbreak in the Indian Ocean island of La ReÄËĂÂĂÂunion in 2005-2006, in which 38.2% of the population was infected and 41.5 million people were documented to have experienced hemorrhagic fever manifestations. Since the re-emergence of CHIKV in La Reunion, epidemic outbreaks of CHIKV infection have been reported globally and CHIKV is now considered endemic in 34 countries across Europe, Australia, Asia and Africa. Mouse monoclonal antibodies that are specific to chikungunya virus can be used as a research or diagnostic reagent to detect infection of cells.
Immunogen: Live chikungunya virus
Isotype: IgG2a
Research area: Microbiology
Myeloma used: Sp2/0-Ag14

Target: N218 epitope on E2 protein of CHIKV
Target background: Chikungunya virus (CHIKV) is known to be transmitted to humans by mosquito vectors, primarily Aedes aegypti and A. albopictus. Symptoms of chikungunya infection generally initiated 4ÄËĂÂĂÂ7 days after the bite of the mosquito vector and usually include high fever, asthenia, chills, headache, diarrhoea, vomiting and rash. CHIKV gained its infamity from the severe outbreak in the Indian Ocean island of La ReÄËĂÂĂÂunion in 2005-2006, in which 38.2% of the population was infected and 41.5 million people were documented to have experienced hemorrhagic fever manifestations. Since the re-emergence of CHIKV in La Reunion, epidemic outbreaks of CHIKV infection have been reported globally and CHIKV is now considered endemic in 34 countries across Europe, Australia, Asia and Africa. Mouse monoclonal antibodies that are specific to chikungunya virus can be used as a research or diagnostic reagent to detect infection of cells.

£ 300
This fee is applicable only for non-profit organizations

Quantity:

For any enquiries, please, contact us .